July 27, 2022 Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S. read more
April 22, 2022 Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis read more
March 1, 2022 Quanterix links up with Eli Lilly for Alzheimer’s blood biomarker testing collaboration read more
December 22, 2021 2022 forecast: Blood test breakthroughs set to move the needle in Alzheimer’s, Parkinson’s research read more
August 22, 2022 How Quanterix’s Breakthrough Device Designation Can Help Change the Trajectory of Alzheimer’s Disease Research read more
March 22, 2021 Ultrasensitive quantification of plasma biomarkers is shaping the future of care for Alzheimer’s disease read more
August 14, 2020 Quanterix Simoa® Technology Powered Nearly 60 Posters And Presentations At Alzheimer’s Association International Conference (AAIC) 2020 read more